Actinium Pharmaceuticals, Inc. (ATNM) Shareholders’ equity 2021–2025
Actinium Pharmaceuticals, Inc. (ATNM) shareholders’ equity at each fiscal year-end, per SEC filings.
$7.8MFY2025 · since FY2021: $73.5M → $7.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.8M | — |
| FY2023 | $36.4M | -45.3% |
| FY2022 | $66.5M | -9.6% |
| FY2021 | $73.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice